Description
- Adjusting your institution’s risk model in lieu of recent MRB legal developments, such as the lawful sale of CBD products on a federal level, while meeting regulatory expectations
- Crafting and conducting business side training on typologies such as commingling of bankable and non-bankable proceeds in order to strengthen monitoring of institutional risks related to marijuana
- Formalizing protocols for reviewing MRB policies and procedures to ensure oversight practices area current and reflect institutional risk appetite and tolerance
https://dvg.ca1.qualtrics.com/jfe/form/SV_8jDMO6LiQ48JV5j
Moderator(s):
Speaker(s):
- Lindsay
M. Dastrup,
CAMS-Audit, CAMS-FCI,
Vice President, Audit Leader,
American Express
- Michael
Greenman,
Senior Vice President, Chief Counsel, AML and Economic Sanctions Law,
U.S. Bank
- Dan
Stipano,
Partner,
Buckley LLP
